Multiple-dose pharmacokinetics, pharmacodynamics and tolerability of the oral ET(A) endothelin-receptor antagonist SPP301 in man

scientific article published on 01 April 2005

Multiple-dose pharmacokinetics, pharmacodynamics and tolerability of the oral ET(A) endothelin-receptor antagonist SPP301 in man is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5414/CPP43178
P698PubMed publication ID15966464

P2093author name stringJ Mann
W Dieterle
K Kutz
P433issue4
P921main subjectpharmacokineticsQ323936
pharmacodynamicsQ725307
P304page(s)178-186
P577publication date2005-04-01
P1433published inInternational Journal of Clinical Pharmacology and TherapeuticsQ15751305
P1476titleMultiple-dose pharmacokinetics, pharmacodynamics and tolerability of the oral ET(A) endothelin-receptor antagonist SPP301 in man
P478volume43

Reverse relations

cites work (P2860)
Q33702404Avosentan for overt diabetic nephropathy
Q46091583Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects

Search more.